674 related articles for article (PubMed ID: 18321598)
21. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
[TBL] [Abstract][Full Text] [Related]
22. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
23. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Sharpe JN; Shively EH; Polk HC
Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
[TBL] [Abstract][Full Text] [Related]
24. Use of linezolid in pediatrics: a critical review.
Dotis J; Iosifidis E; Ioannidou M; Roilides E
Int J Infect Dis; 2010 Aug; 14(8):e638-48. PubMed ID: 20106697
[TBL] [Abstract][Full Text] [Related]
25. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus].
Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S
Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349
[TBL] [Abstract][Full Text] [Related]
26. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL
Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459
[TBL] [Abstract][Full Text] [Related]
27. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
Nathwani D
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii37-44. PubMed ID: 12730141
[TBL] [Abstract][Full Text] [Related]
28. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).
Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D
J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523
[TBL] [Abstract][Full Text] [Related]
29. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
[TBL] [Abstract][Full Text] [Related]
30. Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit.
Sullivan J; Tobias JD
Am J Ther; 2006; 13(6):473-7. PubMed ID: 17122526
[TBL] [Abstract][Full Text] [Related]
31. Tube associated otorrhea in children with recurrent acute otitis media; results of a prospective randomized study on bacteriology and topical treatment with or without systemic antibiotics.
Granath A; Rynnel-Dagöö B; Backheden M; Lindberg K
Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1225-33. PubMed ID: 18565598
[TBL] [Abstract][Full Text] [Related]
32. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Corne P; Marchandin H; Macia JC; Jonquet O
Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
[TBL] [Abstract][Full Text] [Related]
33. MRSA and non-MRSA otorrhea in children: a comparative study of clinical course.
Alexander NS; Kulbersh BD; Heath CH; Desmond RA; Caron E; Woolley AL; Hill JS; Shirley WP; Wiatrak BJ
Arch Otolaryngol Head Neck Surg; 2011 Dec; 137(12):1223-7. PubMed ID: 22183901
[TBL] [Abstract][Full Text] [Related]
34. Methicillin-resistant Staphylococcus aureus colonization in otitis-prone children.
Marzouk HA; Nathawad R; Hammerschlag MR; Weedon J; Bachman D; Goldstein NA
Arch Otolaryngol Head Neck Surg; 2011 Dec; 137(12):1217-22. PubMed ID: 22183900
[TBL] [Abstract][Full Text] [Related]
35. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
37. Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin.
Gebhart BC; Barker BC; Markewitz BA
Pharmacotherapy; 2007 Mar; 27(3):476-9. PubMed ID: 17316160
[TBL] [Abstract][Full Text] [Related]
38. Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y
J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid.
Mogenet I; Raetz-Dillon S; Canonge JM; Archambaud M; Bonnet E
Ann Pharmacother; 2004 Jun; 38(6):986-8. PubMed ID: 15113981
[TBL] [Abstract][Full Text] [Related]
40. Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid.
Serisier DJ; Jones G; Carroll M
J Cyst Fibros; 2004 Mar; 3(1):61. PubMed ID: 15463889
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]